Patent · US Active

Sustained release formulations of nalbuphine

US8394812B2 · kind B2 · utility

6Cited by

1References

57Claims

0Family size

Assignee

PENWEST PHARMACEUTICALS CO. · US

Inventors

Anand R. Baichwal · Wappingers Falls, US
Philip A. Goliber · Lasne, BE
Anthony E. Carpanzano · New Milford, US
Thomas Sciascia · Belmont, US
Donald Diehl, II · New Fairfield, US
Brian Vogler · North White Plains, US
David Verbel · New York, US
Stanley Au · Bethesda, US

Key dates

Filing date	May 23, 2008
Grant date	Mar 12, 2013
Priority date	—
Expiry date	Oct 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.